109 related articles for article (PubMed ID: 11875107)
1. Ligand-selective interactions of ER detected in living cells by fluorescence resonance energy transfer.
Weatherman RV; Chang CY; Clegg NJ; Carroll DC; Day RN; Baxter JD; McDonnell DP; Scanlan TS; Schaufele F
Mol Endocrinol; 2002 Mar; 16(3):487-96. PubMed ID: 11875107
[TBL] [Abstract][Full Text] [Related]
2. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor.
Schaufele F; Chang CY; Liu W; Baxter JD; Nordeen SK; Wan Y; Day RN; McDonnell DP
Mol Endocrinol; 2000 Dec; 14(12):2024-39. PubMed ID: 11117532
[TBL] [Abstract][Full Text] [Related]
3. Analysis of ligand-dependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization.
Ozers MS; Ervin KM; Steffen CL; Fronczak JA; Lebakken CS; Carnahan KA; Lowery RG; Burke TJ
Mol Endocrinol; 2005 Jan; 19(1):25-34. PubMed ID: 15375189
[TBL] [Abstract][Full Text] [Related]
4. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
Bai Y; Giguére V
Mol Endocrinol; 2003 Apr; 17(4):589-99. PubMed ID: 12554772
[TBL] [Abstract][Full Text] [Related]
5. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
[TBL] [Abstract][Full Text] [Related]
6. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
[TBL] [Abstract][Full Text] [Related]
7. Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists.
Huang HJ; Norris JD; McDonnell DP
Mol Endocrinol; 2002 Aug; 16(8):1778-92. PubMed ID: 12145334
[TBL] [Abstract][Full Text] [Related]
8. Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif-Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells.
Bourgoin-Voillard S; Gallo D; Laïos I; Cleeren A; Bali LE; Jacquot Y; Nonclercq D; Laurent G; Tabet JC; Leclercq G
Biochem Pharmacol; 2010 Mar; 79(5):746-57. PubMed ID: 19879249
[TBL] [Abstract][Full Text] [Related]
9. Identification of tamoxifen-induced coregulator interaction surfaces within the ligand-binding domain of estrogen receptors.
Heldring N; Nilsson M; Buehrer B; Treuter E; Gustafsson JA
Mol Cell Biol; 2004 Apr; 24(8):3445-59. PubMed ID: 15060164
[TBL] [Abstract][Full Text] [Related]
10. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
11. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1.
Stenoien DL; Mancini MG; Patel K; Allegretto EA; Smith CL; Mancini MA
Mol Endocrinol; 2000 Apr; 14(4):518-34. PubMed ID: 10770489
[TBL] [Abstract][Full Text] [Related]
12. Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.
Bramlett KS; Wu Y; Burris TP
Mol Endocrinol; 2001 Jun; 15(6):909-22. PubMed ID: 11376110
[TBL] [Abstract][Full Text] [Related]
13. A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment.
Liu J; Knappenberger KS; Kack H; Andersson G; Nilsson E; Dartsch C; Scott CW
Mol Endocrinol; 2003 Mar; 17(3):346-55. PubMed ID: 12554768
[TBL] [Abstract][Full Text] [Related]
14. Development of a coactivator displacement assay for the orphan receptor estrogen-related receptor-gamma using time-resolved fluorescence resonance energy transfer.
Gowda K; Marks BD; Zielinski TK; Ozers MS
Anal Biochem; 2006 Oct; 357(1):105-15. PubMed ID: 16889744
[TBL] [Abstract][Full Text] [Related]
15. Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene.
Levy N; Zhao X; Tang H; Jaffe RB; Speed TP; Leitman DC
Endocrinology; 2007 Jul; 148(7):3449-58. PubMed ID: 17395694
[TBL] [Abstract][Full Text] [Related]
16. Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries.
Northrop JP; Nguyen D; Piplani S; Olivan SE; Kwan ST; Go NF; Hart CP; Schatz PJ
Mol Endocrinol; 2000 May; 14(5):605-22. PubMed ID: 10809226
[TBL] [Abstract][Full Text] [Related]
17. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant.
Sauvé F; McBroom LD; Gallant J; Moraitis AN; Labrie F; Giguère V
Mol Cell Biol; 2001 Jan; 21(1):343-53. PubMed ID: 11113208
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
[TBL] [Abstract][Full Text] [Related]
19. Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription.
Llopis J; Westin S; Ricote M; Wang Z; Cho CY; Kurokawa R; Mullen TM; Rose DW; Rosenfeld MG; Tsien RY; Glass CK
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4363-8. PubMed ID: 10760302
[TBL] [Abstract][Full Text] [Related]
20. Development of peptide antagonists that target estrogen receptor beta-coactivator interactions.
Hall JM; Chang CY; McDonnell DP
Mol Endocrinol; 2000 Dec; 14(12):2010-23. PubMed ID: 11117531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
